Table 2 Fully-adjusted, survey-weighted associations between serum PBDE concentrations and having a current thyroid problem. Adjusted for: age, race/ethnicity, BMI, education, smoking, alcohol consumption, and current hormone use
From: PBDE flame retardants, thyroid disease, and menopausal status in U.S. women
|  | BDE47 n = 1075 | BDE99 n = 1061 | BDE100 n = 1089 | BDE153 n = 1089 | Sum BDEs n = 1061 | |||||
| Â | OR | (95Â % CI) | OR | (95Â % CI) | OR | (95Â % CI) | OR | (95Â % CI) | OR | (95Â % CI) |
Men and Women Combined | ||||||||||
Q1 + Q2 (ref) | 1 |  | 1 |  | 1 |  | 1 |  | 1 |  |
Q3 | 0.55 | (0.20–1.49) | 0.93 | (0.38–2.27) | 0.74 | (0.44–1.25) | 0.92 | (0.30–2.84) | 0.57 | (0.23–1.39) |
Q4 | 1.32 | (0.90–1.96) | 1.22 | (0.80–1.84) | 1.13 | (0.79–1.60) | 1.14 | (0.56–2.31) | 1.09 | (0.71–1.67) |
|  | BDE47 n = 512 | BDE99 n = 504 | BDE100 n = 518 | BDE153 n = 518 | Sum BDEs n = 504 | |||||
All Women | ||||||||||
Q1 + Q2 (ref) | 1 |  | 1 |  | 1 |  | 1 |  | 1 |  |
Q3 | 0.60 | (0.19–1.85) | 0.75 | (0.27–2.08) | 0.65 | (0.27–1.54) | 1.00 | (0.27–3.78) | 0.36** | (0.15–0.89) |
Q4 | 1.48** | (1.05–2.09) | 1.78** | (1.16–2.75) | 1.50* | (0.97–2.31) | 1.44 | (0.68–3.05) | 1.61** | (1.10–2.36) |
|  | BDE47 n = 236 | BDE99 n = 233 | BDE100 n = 240 | BDE153 n = 240 | Sum BDEs n = 233 | |||||
Postmenopausal Women | ||||||||||
Q1 + Q2 (ref) | 1 |  | 1 |  | 1 |  | 1 |  | 1 |  |
Q3 | 0.81 | (0.24–2.71) | 0.99 | (0.34–2.93) | 0.23** | (0.07–0.68) | 0.50 | (0.13–1.90) | 0.54 | (0.15–1.97) |
Q4 | 2.15* | (0.86–5.37) | 3.63** | (1.12–11.8) | 2.02* | (0.93–4.36) | 1.25 | (0.49–3.21) | 2.20* | (0.92–5.26) |